Journal home
Advance online publication
Current issue
Archive
Press releases
Supplements and Focuses
Image gallery
Guide to authors
Online submissionOnline submission
Permissions
For referees
Free online issue
Contact the journal
Subscribe
Advertising
work@npg
naturereprints
About this site
For librarians
 
NPG Resources
Nature
Nature Reviews Molecular Cell Biology
UCSD-Nature Signaling Gateway
The Cell Migration Gateway
Nature Reports Stem Cells
Nature Reports Avian Flu
NPG Subject areas
Biotechnology
Cancer
Chemistry
Clinical Medicine
Dentistry
Development
Drug Discovery
Earth Sciences
Evolution & Ecology
Genetics
Immunology
Materials Science
Medical Research
Microbiology
Molecular Cell Biology
Neuroscience
Pharmacology
Physics
Browse all publications
Article
Nature Cell Biology  4, 658 - 665 (2002)
Published online: 12 August 2002; | doi:10.1038/ncb840

Akt regulates growth by directly phosphorylating Tsc2

Christopher J. Potter, Laura G. Pedraza & Tian Xu

Howard Hughes Medical Institute, Department of Genetics, Yale University School of Medicine, Boyer Center for Molecular Medicine, 295 Congress Avenue, New Haven, CT 06536-0812, USA

Correspondence should be addressed to Tian Xu tian.xu@yale.edu
The direct mechanism by which the serine/threonine kinase Akt (also known as protein kinase B (PKB)) regulates cell growth is unknown. Here, we report that Drosophila melanogaster Akt/PKB stimulates growth by phosphorylating the tuberous sclerosis complex 2 (Tsc2) tumour suppressor and inhibiting formation of a Tsc1−Tsc2 complex. We show that Akt/PKB directly phosphorylates Drosophila Tsc2 in vitro at the conserved residues, Ser 924 and Thr 1518. Mutation of these sites renders Tsc2 insensitive to Akt/PKB signalling, increasing the stability of the Tsc1−Tsc2 complex within the cell. Stimulating Akt/PKB signalling in vivo markedly increases cell growth/size, disrupts the Tsc1−Tsc2 complex and disturbs the distinct subcellular localization of Tsc1 and Tsc2. Furthermore, all Akt/PKB growth signals are blocked by expression of a Tsc2 mutant lacking Akt phosphorylation sites. Thus, Tsc2 seems to be the critical target of Akt in mediating growth signals for the insulin signalling pathway.

MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated

REVIEWS
Opinion: Searching for the elusive targets of farnesyltransferase inhibitors
Nature Reviews Cancer Perspective (01 Dec 2003)
 See all 4 matches for Reviews

NEWS AND VIEWS
TSC1–TSC2: a complex tale of PKB-mediated S6K regulation
Nature Cell Biology News and Views (01 Sep 2002)

RESEARCH
Rheb is a direct target of the tuberous sclerosis tumour suppressor proteins
Nature Cell Biology Brief Communications (01 Jun 2003)
TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling
Nature Cell Biology Article (01 Sep 2002)
Tsc tumour suppressor proteins antagonize amino-acid–TOR signalling
Nature Cell Biology Brief Communication (01 Sep 2002)
 See all 8 matches for Research

 Top
Abstract
Previous | Next
Table of contents
Full textFull text
Download PDFDownload PDF
Send to a friendSend to a friend
Save this linkSave this link

Open Innovation Challenges

naturejobs

Figures & Tables
Supplementary info
See also: News and Views by McManus & Alessi
Export citation
natureproducts

Search buyers guide:

 
ADVERTISEMENT
 
Nature Cell Biology
ISSN: 1465-7392
EISSN: 1476-4679
Journal home | Advance online publication | Current issue | Archive | Press releases | For authors | Online submission | For referees | Free online issue | About the journal | Contact the journal | Subscribe | Advertising | work@npg | Reprints and permissions | About this site | For librarians
Nature Publishing Group, publisher of Nature, and other science journals and reference works©2002 Nature Publishing Group | Privacy policy